Learn more

SINPHAR PHARMACEUTICAL CO LTD

Overview
  • Total Patents
    66
  • GoodIP Patent Rank
    80,141
  • Filing trend
    ⇩ 33.0%
About

SINPHAR PHARMACEUTICAL CO LTD has a total of 66 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 1998. It filed its patents most often in Taiwan, United States and China. Its main competitors in its focus markets pharmaceuticals, foods and drinks and measurement are FLEX PHARMA INC, TOKIWA PHYTOCHEMICAL CO LTD and PT DEXA MEDICA.

Patent filings in countries

World map showing SINPHAR PHARMACEUTICAL CO LTDs patent filings in countries

Patent filings per year

Chart showing SINPHAR PHARMACEUTICAL CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lin Hang-Ching 22
#2 Huang Hsin-Wen 17
#3 Chao Chien-Lian 15
#4 Chang Wen-Liang 15
#5 Lin Hang Ching 14
#6 Ding Hsiou-Yu 13
#7 Lei Li 8
#8 Chang Wen Liang 8
#9 Tu Pengfei 8
#10 Tseng Jerming 8

Latest patents

Publication Filing date Title
US2018243360A1 Anti-fatigue composition used for increasing endurance performance, and use of the same
TW201811350A Uses ofporia cocosextract and its active ingredients in protecting skin and/or promoting wound healing
US2017326188A1 Uses of poria cocos epidermis extract, poricoic acid a, and poricoic acid b in regulating blood glucose level
TW201739450A Uses of poria cocos epidermis extract, poricoic acid a, and poricoic acid b in regulating blood glucose level
TW201601740A Cistanche tubulosa extract for the preparation of medicines or foods for the protection of ocular cells
TW201544114A Fu-ling extract and preparation method and use of the same
US2014357581A1 Method for regulating blood glucose level
TW201200137A Use of isoacteoside or pharmaceutically acceptable salt thereof in inhibiting formation, accumulation or aggregation of amyloid beta peptides, and in fabrication of drug for preventing or treating amyloid beta peptide-associated diseases or conditions
TW201106958A Use of lanostane and poria extract in treating diabetic
TW201100078A Pharmaceutical composition for the treatment and prophylaxis of a disorder induced from myocardial ischemia
US2009318399A1 Pharmaceutical composition and extract of poria for treating a disease induced from immune disorder
TW201039832A Use of lanostane and poria extract in treating cachexia
US2008261896A1 Testosterone generating and metabolizing enhancer
TW200940072A Pharmaceutical composition and extract of poria for enhancing uptake of nutrients
EP1714645A1 Pharmaceutical composition containing bakuchiol for treating breast cancer in women
EP1714646A1 Pharmaceutical composition containing bakuchiol for treating osteoporosis in women
CN1827090A Medicinal composition containing backuchiol for treating female osteoporosis
CN1827091A Medicinal composition containing backuchiol for treating female breast cancer
KR20050110379A Pharmaceutical composition immunity, and extract of poria
TW200536548A Pharmaceutical composition containing bakuchiol for treating woman breast cancer